Skip to contentB
BioMarin Pharmaceutical Inc
B
BMRNBioMarin Pharmaceutical Inc BMRN Q4 2011 · BioMarin Pharmaceutical Inc · ThalerSource filing unavailable
Q4 2011 · —
derived · Computed from the longer spans the company filed.
Revenue$107.85M$107.85Mderived+6.1% vs Q4 2010 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
−4.9% vs Q3 2011
Net Income-$26.74M-$26.74MderivedN/M vs Q4 2010N/M vs Q3 2011 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$21,435,000N/M Operating Cash Flowderived-$513,000N/M Free Cash Flowderived-$9,193,000N/M Margins · derivedOperating margin-19.9%−16.6 pt vs Q4 2010
Net margin-24.8%−12.8 pt vs Q4 2010